AIによるがん診断の世界市場レポート 2025年

AIによるがん診断市場規模は、今後数年で急成長が見込まれます。2029年には16億4,000万米ドルに成長し、CAGRは19.9％となります。予測期間の成長は、説明可能なAIの出現、ヘルスケア支出の世界的増加、電子カルテ（EHR）との統合、個別化医療の採用、AIアルゴリズムの継続的進歩に起因します。予測期間の主な動向には、イメージング技術の進歩、技術的融合、ヘルスケアとハイテク企業のコラボレーション、デジタル病理学の台頭、病理組織学の自動化などが含まれます。

がんの有病率の上昇は、がん診断市場における人工知能の成長を促進すると予想されます。がんは、体の他の部分に浸潤または転移する可能性のある異常な細胞増殖を特徴とする疾患群を指します。がん治療におけるAIの統合は、効率性、正確性、個別化された治療選択肢を改善し、最終的にがん患者の転帰を向上させることを目的としています。例えば、2024年5月、米国の政府機関である国立がん研究所は、2024年に米国で新たに約200万人のがん患者が診断され、61万1000人以上の死亡が予想されると予測しました。2040年までに、世界の新規がん患者は2990万人に増加し、がん関連死は1530万人に達すると予測されています。その結果、がん有病率の増加が、がん診断市場における人工知能の採用を促進しています。

AIによるがん診断市場の主要企業は、がん診断のためのAI搭載デジタル病理ソリューションの進歩によって顕著な成長を遂げています。これらのソリューションは、AIアルゴリズムを活用してさまざまな組織タイプでがんやその他の診断上の特徴を検出し、正確でタイムリーながん診断を提供し、症例の優先順位付けをサポートし、再現性のある診断を保証します。例えば、2023年11月、DedalusとIbex Medical Analyticsは、欧州全域でがん診断のための統合End-to-End AI搭載デジタル病理ソリューションを発表しました。このソリューションは、精度の向上、AIを活用した意思決定支援ツールの提供、報告の合理化、検査室の効率改善、診断の信頼性向上を目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界AIによるがん診断 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のAIによるがん診断市場：成長率分析
• 世界のAIによるがん診断市場の実績：規模と成長, 2019-2024
• 世界のAIによるがん診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界AIによるがん診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のAIによるがん診断市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトウェアソリューション
• ハードウェア
• サービス
• 世界のAIによるがん診断市場がんの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳がん
• 肺がん
• 脳腫瘍
• 皮膚がんと子宮頸がん
• 前立腺がんと大腸がん
• その他のがんの種類
• 世界のAIによるがん診断市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• スクリーニングと診断
• 腫瘍の特定
• 監視
• 世界のAIによるがん診断市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• 医療調査機関
• 契約調査機関
• 世界のAIによるがん診断市場ソフトウェアソリューションのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機械学習ソフトウェア
• ディープラーニングソフトウェア
• 画像解析ソフトウェア
• 世界のAIによるがん診断市場、ハードウェアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• AI搭載画像システム
• 診断装置
• 世界のAIによるがん診断市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• AI統合サービス
• コンサルティングおよびトレーニングサービス
• サポートおよびメンテナンスサービス

第7章 地域別・国別分析

• 世界のAIによるがん診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のAIによるがん診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• AIによるがん診断市場：競合情勢
• AIによるがん診断市場：企業プロファイル
  • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Babylon Healthcare Services Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis
  • Tempus Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Guardant Health
• Lunit Inc.
• Paige AI Inc.
• Ada Health GmbH
• Viz.ai Inc.
• Butterfly Network Inc.
• Insilico Medicine
• BenevolentAI SA SA
• Enlitic Inc.
• Ibex Medical Analytics
• Kheiron Medical Technologies Limited
• CureMetrix Inc.
• CancerIQ Inc.
• MultiplAI Health
• Freenome Holdings Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• AIによるがん診断市場2029：新たな機会を提供する国
• AIによるがん診断市場2029：新たな機会を提供するセグメント
• AIによるがん診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

AI in cancer diagnostics involves employing artificial intelligence technologies such as machine learning and deep learning to analyze medical images, genetic data, or patient histories for aiding in the early detection, diagnosis, and prognosis of cancer. These systems can detect patterns and anomalies in data that may elude human perception, thereby enhancing diagnostic accuracy and efficiency.

The primary components of AI in cancer diagnostics include software solutions, hardware, and services. Software solutions utilize artificial intelligence (AI) and machine learning (ML) technologies to enhance the accuracy and efficiency of cancer detection, prognosis, and treatment selection. Various types of cancer, including breast cancer, lung cancer, brain tumors, skin cancer, cervical cancer, prostate cancer, colorectal cancer, and others, are addressed. These applications encompass screening and diagnosis, tumor identification, and monitoring, and are utilized by a range of end-users such as hospitals, diagnostic centers, medical research institutes, and contract research organizations.

The AI in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides AI in cancer diagnostics market statistics, including AI in cancer diagnostics industry global market size, regional shares, competitors with an AI in cancer diagnostics market share, detailed AI in cancer diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in cancer diagnostics industry. This AI in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The AI in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.66 billion in 2024 to $0.79 billion in 2025 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, data explosion in healthcare, supportive regulatory environment, focus on precision medicine, expansion of AI applications beyond imaging.

The AI in cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.64 billion in 2029 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to emergence of explainable AI, global increase in healthcare it spending, integration with electronic health records (EHR), personalized medicine adoption, continued advances in AI algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, rise of digital pathology, automation in histopathology.

The rising prevalence of cancer is expected to drive the growth of artificial intelligence in the cancer diagnostics market. Cancer refers to a group of diseases characterized by abnormal cell growth that can invade or spread to other parts of the body. The integration of AI in cancer care aims to improve efficiency, accuracy, and personalized treatment options, ultimately enhancing outcomes for cancer patients. For example, in May 2024, the National Cancer Institute, a US-based government agency, projected that approximately 2 million new cancer cases would be diagnosed in the U.S. in 2024, with over 611,000 deaths expected. By 2040, global new cancer cases are anticipated to rise to 29.9 million, with cancer-related deaths reaching 15.3 million. As a result, the growing prevalence of cancer is driving the adoption of artificial intelligence in the cancer diagnostics market.

Leading companies in the AI in cancer diagnostics market are experiencing notable growth driven by advancements in AI-powered digital pathology solutions for cancer diagnosis. These solutions utilize AI algorithms to detect cancer and other diagnostic features in various tissue types, offering accurate and timely cancer diagnosis, supporting case prioritization, and ensuring reproducible diagnoses. For instance, in November 2023, Dedalus & Ibex Medical Analytics introduced an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to enhance accuracy, provide AI-powered decision support tools, streamline reporting, improve laboratory efficiency, and boost diagnostic confidence.

In December 2023, Lunit, a South Korean AI company, acquired Volpara for $193 million, aiming to establish the combined entity as a leading force in AI-driven cancer diagnostics, particularly in the U.S. market. Volpara's extensive presence in over 2,000 medical sites across the U.S. and its vast database of over 100 million high-quality mammogram images position it as a valuable addition to Lunit's capabilities. Volpara, based in New Zealand, specializes in providing AI-powered software for personalized screening and early detection of breast cancer.

Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the AI in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

AI in the cancer diagnostics market consists of revenues earned by entities by providing services such as early detection and screening, image analysis and interpretation, predictive analytics, and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in Cancer Diagnostics market also consists of sales of medical imaging devices, pathology analysis systems, genomic sequencing equipment, and patient monitoring devices that are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software Solutions; Hardware; Services
• 2) By Cancer Type: Breast Cancer; Lung Cancer; Brain Tumor; Skin Cancer And Cervical Cancer; Prostate And Colorectal Cancer; Other Cancer Types
• 3) By Application: Screening And Diagnosis; Tumor Identification; Monitoring
• 4) By End User: Hospitals; Diagnostic Centers; Medical Research Institutes; Contract Research Organizations
• Subsegments:
• 1) By Software Solutions: Machine Learning Software; Deep Learning Software; Image Analysis Software
• 2) By Hardware: AI-Powered Imaging Systems; Diagnostic Devices
• 3) By Services: AI Integration Services; Consulting And Training Services; Support And Maintenance Services
• Companies Mentioned: Microsoft Corporation; IBM Corporation; Babylon Healthcare Services Ltd.; Verily Life Sciences LLC; Tempus
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Cancer Diagnostics Market Characteristics

3. AI In Cancer Diagnostics Market Trends And Strategies

4. AI In Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global AI In Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global AI In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global AI In Cancer Diagnostics Market Growth Rate Analysis
• 5.4. Global AI In Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global AI In Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global AI In Cancer Diagnostics Total Addressable Market (TAM)

6. AI In Cancer Diagnostics Market Segmentation

• 6.1. Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software Solutions
• Hardware
• Services
• 6.2. Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Lung Cancer
• Brain Tumor
• Skin Cancer And Cervical Cancer
• Prostate And Colorectal Cancer
• Other Cancer Types
• 6.3. Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Screening And Diagnosis
• Tumor Identification
• Monitoring
• 6.4. Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Medical Research Institutes
• Contract Research Organizations
• 6.5. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Machine Learning Software
• Deep Learning Software
• Image Analysis Software
• 6.6. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Powered Imaging Systems
• Diagnostic Devices
• 6.7. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI Integration Services
• Consulting And Training Services
• Support And Maintenance Services

7. AI In Cancer Diagnostics Market Regional And Country Analysis

• 7.1. Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Cancer Diagnostics Market

• 8.1. Asia-Pacific AI In Cancer Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Cancer Diagnostics Market

• 9.1. China AI In Cancer Diagnostics Market Overview
• 9.2. China AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Cancer Diagnostics Market

• 10.1. India AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Cancer Diagnostics Market

• 11.1. Japan AI In Cancer Diagnostics Market Overview
• 11.2. Japan AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Cancer Diagnostics Market

• 12.1. Australia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Cancer Diagnostics Market

• 13.1. Indonesia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Cancer Diagnostics Market

• 14.1. South Korea AI In Cancer Diagnostics Market Overview
• 14.2. South Korea AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Cancer Diagnostics Market

• 15.1. Western Europe AI In Cancer Diagnostics Market Overview
• 15.2. Western Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Cancer Diagnostics Market

• 16.1. UK AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Cancer Diagnostics Market

• 17.1. Germany AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Cancer Diagnostics Market

• 18.1. France AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Cancer Diagnostics Market

• 19.1. Italy AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Cancer Diagnostics Market

• 20.1. Spain AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Cancer Diagnostics Market

• 21.1. Eastern Europe AI In Cancer Diagnostics Market Overview
• 21.2. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Cancer Diagnostics Market

• 22.1. Russia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Cancer Diagnostics Market

• 23.1. North America AI In Cancer Diagnostics Market Overview
• 23.2. North America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Cancer Diagnostics Market

• 24.1. USA AI In Cancer Diagnostics Market Overview
• 24.2. USA AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Cancer Diagnostics Market

• 25.1. Canada AI In Cancer Diagnostics Market Overview
• 25.2. Canada AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Cancer Diagnostics Market

• 26.1. South America AI In Cancer Diagnostics Market Overview
• 26.2. South America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Cancer Diagnostics Market

• 27.1. Brazil AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Cancer Diagnostics Market

• 28.1. Middle East AI In Cancer Diagnostics Market Overview
• 28.2. Middle East AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Cancer Diagnostics Market

• 29.1. Africa AI In Cancer Diagnostics Market Overview
• 29.2. Africa AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Cancer Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. AI In Cancer Diagnostics Market Competitive Landscape
• 30.2. AI In Cancer Diagnostics Market Company Profiles
  • 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Babylon Healthcare Services Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Tempus Overview, Products and Services, Strategy and Financial Analysis

31. AI In Cancer Diagnostics Market Other Major And Innovative Companies

• 31.1. Guardant Health
• 31.2. Lunit Inc.
• 31.3. Paige AI Inc.
• 31.4. Ada Health GmbH
• 31.5. Viz.ai Inc.
• 31.6. Butterfly Network Inc.
• 31.7. Insilico Medicine
• 31.8. BenevolentAI SA SA
• 31.9. Enlitic Inc.
• 31.10. Ibex Medical Analytics
• 31.11. Kheiron Medical Technologies Limited
• 31.12. CureMetrix Inc.
• 31.13. CancerIQ Inc.
• 31.14. MultiplAI Health
• 31.15. Freenome Holdings Inc.

32. Global AI In Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Cancer Diagnostics Market

34. Recent Developments In The AI In Cancer Diagnostics Market

35. AI In Cancer Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 AI In Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 AI In Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 AI In Cancer Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer